DiappyMed logo — Alléger le diabète avec des outils digitaux dont une thérapi...

DiappyMed

Alléger le diabète avec des outils digitaux dont une thérapie numérique pour personnaliser le dosage d’insuline

Founded 2021 France France 16 employees Health Care, Manufacturing

General Information

Company Name DiappyMed
Founded Year 2021
Location France France
Employees 16
Industries Health Care, Manufacturing
Social

BounceWatch is an independent company data service, not affiliated with DiappyMed. To contact DiappyMed, visit diappymed.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does DiappyMed compare?

A PDF of DiappyMed and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting DiappyMed soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About DiappyMed

DiappyMed, founded in 2021 and based in France, is a pioneering company in the Health Care and Manufacturing industries. Their focus is on enhancing the lives of individuals with diabetes (Type 1 and 2) by integrating cutting-edge digital solutions.

With the slogan "Alléger le diabète avec des outils digitaux," DiappyMed offers two primary products: EkiYou Carbs, a mobile application for precise carbohydrate counting, and EkiYou, a digital therapy facilitating insulin dose recommendations tailored to meals, physical activity, and glycemia levels. Notably, EkiYou holds the CE Class IIb medical device certification.

These tools are developed in collaboration with a robust medical committee and a dedicated patient community, comprising 2000 users, ensuring clinical relevance and user-centric design. While DiappyMed has yet to benefit from external investments, its innovation and dedication to user-focused diabetes management position it as an appealing prospect for future investors seeking impact-driven healthcare solutions.

Business keywords: Digital Health, Diabetes Management, Insulin Dosage Optimization, Glycemic Control, Carbohydrate Counting, Digital Therapy, Mobile Health Applications, Basal-Bolus Insulin Regimen, Class IIb Medical Device, CE Marked Products, Patient-Centric Solutions, Diabetology, Patient Community Involvement, Nutrition Information, Clinical Validation

Services & Products

Insulin dosage application
Carbohydrate counting mobile application
Digital therapy for diabetes

Target Customers

Patients with diabetes Type 1 diabetics Healthcare professionals Medical institutions

No funding data available for DiappyMed yet.

DiappyMed Alternatives & Competitors

View All Alternatives
DiappyMed vs
Abbott
Abbott United States

Life-changing health technologies in the area of diagnostics, medical devices, nutritionals and bran...

IPO
152808 employees
Biotechnology, Health Care
DiappyMed vs

Enriching Lives: Delivering High-Quality, Effective Products for Diabetes and Metabolic Disorders

143 employees
Health Care, Manufacturing
DiappyMed vs
SeeMedX
SeeMedX United States

Noninvasive monitors and telehealth devices that save lives, reduce healthcare costs and increase cl...

11 employees
Health Care, Manufacturing

FAQ About DiappyMed

Alléger le diabète avec des outils digitaux dont une thérapie numérique pour personnaliser le dosage d’insuline
DiappyMed was founded in 2021.
DiappyMed is headquartered in France.
DiappyMed operates in Health Care and Manufacturing. Its work centres on Digital Health, Diabetes Management, Insulin Dosage Optimization and Glycemic Control. Its customers include Patients with diabetes, Type 1 diabetics and Healthcare professionals.
DiappyMed has approximately 16 employees.
DiappyMed offers: Insulin dosage application, Carbohydrate counting mobile application, Digital therapy for diabetes.
Top alternatives and competitors to DiappyMed include Abbott, Primus Remedies Pvt Ltd, SeeMedX, AskBio Inc., Insight Lifetech Co., Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
DiappyMed and Abbott are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for DiappyMed, https://bouncewatch.com/company/diappymed, updated 23 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes